Three of the allo-HSCT cohort were also IgA deficient prior to LTx, 1 of which was receiving immunoglobulin replacement therapy for co-existing IgG deficiency. This evidence concerns the gene CD79A and hyperinsulinemic hypoglycemia, familial, 4.